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Abstract
The complete DNA sequence and transcription map of human adenovirus type 11 are reported here. This is the first published sequence
for a subgenera B human adenovirus and demonstrates a genome organization highly similar to those of other human adenoviruses. All of
the genes from the early, intermediate, and late regions are present in the expected locations of the genome for a human adenovirus. The
genome size is 34,794 bp in length and has a GC content of 48.9%. Sequence alignment with genomes of groups A (Ad12), C (Ad5), D
(Ad17), E (Simian adenovirus 25), and F (Ad40) revealed homologies of 64, 54, 68, 75, and 52%, respectively. Detailed genomic analysis
demonstrated that Ads 11 and 35 are highly conserved in all areas except the hexon hypervariable regions and fiber. Similarly, comparison
of Ad11 with subgroup E SAV25 revealed poor homology between fibers but high homology in proteins encoded by all other areas of the
genome. We propose an evolutionary model in which functional viruses can be reconstituted following fiber substitution from one serotype
to another. According to this model either the Ad11 genome is a derivative of Ad35, from which the fiber was substituted with Ad7, or the
Ad35 genome is the product of a fiber substitution from Ad21 into the Ad11 genome. This model also provides a possible explanation for
the origin of group E Ads, which are evolutionarily derived from a group C fiber substitution into a group B genome.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Adenoviruses (Ads) can be divided into five genera en-
compassing the Atadenovirus, Aviadenoviridae, Mastade-
noviridae (infecting mammals), Siadenoviridae, and unclas-
sified Adenoviridae (for discussion, see Benko et al., 2002).
Ads have linear dsDNA genomes that contain inverted ter-
minal repeat sequences (ITRs) and both contain an origin of
replication. Depending on the genera and species origin the
genome organization can differ, but they all produce a
number of early (E) and late (L) RNA transcripts. In addi-
tion, divergent intermediate genes and virus-associated
(VA) RNA gene species are found.
Within the Mastadenoviridae 51 different serotypes of
human Ad have been identified and they can be classified
into six subgenera (groups A–F). Each serotype is deter-
mined by its neutralization and the subgenera classification
is based on a variety of parameters including hemaggluti-
nation, oncogenicity in rodents, electrophoretic mobility
(Wadell, 1979) and genome homology (Garon et al., 1973).
The group B Ads have been divided further into two groups
showing DNA homology that include Ad3, 7, 16, and 21
(B:1), or Ad11, 14, 34, 35, and 50 (B:2). The B:1 viruses
were isolated from patients with respiratory tract infections,
while the B:2 viruses, with the exception of Ad11a and 14
(Mei et al., 1998; Van der Veen et al., 1963), are described
as causing kidney and urinary tract infections (Hierholzer et
al., 1975; Myerowitz et al., 1975; Shields et al., 1985;
Shindo et al., 1986).
Of the B:2 Ads, serotypes 11, 34, and 35 are the most
closely related and share highly homologous comigration
patterns following genome restriction digestion (Li et al.,
1991). Ad 11 has been classified into at least two genome
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types termed Ad11p and Ad11a (Li et al., 1991) that have
been found in different regions of the world. Ad11p was
first isolated from a patient with a urinary tract infection that
developed into a kidney infection and has been found in
Europe, America, and Japan (Mufson et al., 1973; Mufson
and Belshe, 1976; Numazaki et al., 1968; Shindo et al.,
1986). Ad11a was isolated from patients with acute respi-
ratory tract infections and has been found in China, Spain,
and Latin America (Hierholzer et al., 1975; Kajon et al.,
1996; Zhang et al., 1985).
Subgroup B Ads are the only group with no proven
affinity for the coxsackie and adenovirus receptor (CAR)
(Roelvink et al., 1998). Cross-competition binding experi-
ments between Ad3 and Ad35 suggest that at least two
receptors may exist between B:1 and B:2 viruses (Shayakh-
metov et al., 2000), while differential competition between
different strains of Ad11 indicate that more than one recep-
tor may also exist for B:2 viruses (Mei et al., 1998). This
receptor diversity implies that group B viruses have a dif-
ferent tropism than CAR-interacting Ads and as such can
provide an alternative to Ad5-based gene transfer vectors.
Group B:2 Ads, in particular serotypes 11, 35, and 50 fibers,
have shown the ability to efficiently bind to human hema-
topoietic cells (Knaan-Shanzer et al., 2001; Segerman et al.,
2000; Shayakhmetov et al., 2000), a significant target for
treatment of genetic immune and blood disorders. This
observation has led to development of “gutted” Ad vector
systems utilizing chimeric Ad11 and 35 fibers which can be
used to stably transduce human hematopoietic cells (Shayakh-
metov et al., 2002; Stecher et al., 2001). Further develop-
ments may lead to the production of helper-dependent vec-
tors utilizing capsids from Ad11 or 35 as has been done
previously for Ad5 (Parks et al., 1996; Sandig et al., 2000;
Umana et al., 2001).
In this study we have sequenced the genome of human
Ad11, which shows typical organization and characteristics
for a human adenovirus. Transcription units for 4 early, 1
VA RNA, 2 intermediate, and 5 late regions were identified.
Phylogenetic analysis and evolutionary comparisons were
carried out for nonstructural (DNA-binding protein, DBP)
and structural (hexon and fiber) proteins. Nonstructural
DBP showed closest identity with group B serotype Ad7
followed by group E serotype Ad4. Analysis of the hexon
protein revealed that Ad11 hexon is phylogenetically clus-
tered with group B serotypes 35, 21, and 34, while Ad11p
fiber is phylogenetically clustered with group B serotypes
7a, 7d, 11a, 14, and 34a. Furthermore, we suggest a model
for Ad evolution in which fibers can be swapped between
the genomes of alternate serotypes to reconstitute functional
virus and likely explains the origins of Ad11 and the group
E serotypes.
Results and discussion
General properties
The genome of Ad11 is 34,794 bp in length and the plus
strand has a base composition of 24.5% G, 24.4% C, 26%
A, and 25.1% T. Generally, group A, B, C, D, and E Ads
have GC percentages of 48–49, 50–52, 57–59, 57–61, and
57–59%, respectively (Shenk, 1996) and the overall GC
content of Ad11 at 48.9% was found to be slightly lower
than other group B Ads. As reported for the previously
Fig. 1. Transcription map and genome organization of human Ad11. The schematic map of the Ad11 genome (34,794 bp) is divided into 100 map units (m.u.)
and encompasses the left (l) and right (r) strands. Protein coding regions and the direction of transcription are identified by solid arrows, while early (E1–4)
and late (L1–5) transcription units are shown in parentheses. The major late promoter (MLP) is indicated by a downward arrowhead. The tripartite leader
(TPL) segments 1–3, which are found at the beginning of all late viral mRNAs, are represented by solid vertical lines on the l-strand. The location of the
VA RNA is indicated by an open arrowhead.
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sequenced Ads from subgroups A, C, D, and F, Ad11 shows
a highly organized genome with four early, two intermedi-
ate, and five late transcription regions present (Fig. 1).
The ITRs were found to be 137 bp in length and at the
extreme termini a CATCATCAAT motif was seen that is
also present in serotypes 18, 31 (A), 34, 35 (B), 5 (C), 17
(D), and 40, 41 (F). Within ITRs cis replication elements are
conserved among Ad serotypes and between base pairs 9
and 18 the conserved ATAATATACC motif was found that
is known to directly interact with a complex of pTP and
polymerase during viral DNA replication (Temperley and
Hay, 1992). DNA replication is a prerequisite for homolo-
gous recombination and hence the evolution of Ads. Over-
all, the ITR sequence was most homologous to the group B
serotypes (3  7  34  35).
The Ad5 packaging signal as determined by Hearing and
colleagues contains seven elements termed AI–AVII corre-
sponding to nucleotides 240–377 (Grable and Hearing,
1990; Schmid and Hearing, 1997). When the left end of the
Ad11 genome is aligned with Ad5, a 70.5% homology is
found with nucleotides 247–387 and A repeats I–VII are
also present. Further alignment with group B serotypes 3, 7,
and 35 revealed 83.2, 83.9, and 99.3% homology, respec-
tively. It is known that during virus assembly the packaging
signal must interact with accessory proteins, including the
adenovirus IVa2 protein, in order to become packaged and
that this interaction can be serotype specific (Zhang et al.,
2001). The diversity in packaging signals seen among se-
rotypes likely represents differences in the accessory pro-
teins involved in packaging of different serotypes.
VA RNA
The virus-associated RNAs are a class of abundant, low
molecular weight RNA species found in cells following Ad
infection (Reich et al., 1966). The sequence for the Ad11
VA RNA has previously been reported by two other groups
and is 100% identical to the sequence reported here (Table
1). For Ad11 the VA RNA sequence is located at nucleo-
tides 10432–10589.
E1
The E1 transcription unit has two regions, termed E1A
and E1B, that encode for proteins which play major roles
early in the adenovirus infection cycle (for detailed review,
see Shenk and Flint, 1991; Shenk, 1996). The putative
transcription initiation start site for Ad11 E1A was identi-
fied as a TATTTATA sequence. Based on the predicted
6.3-, 24-, and 28-kDa proteins reported for Ad7 (Dijkema et
al., 1980) three predicted E1A proteins of 6.3, 25.7, and
29.1 kDa were found for Ad11. For E1B the putative tran-
scription initiation site was found to be a TATATAAG
sequence. Similarly, three predicted proteins of 20, 54.9,
and 10 kDa were identified for Ad11 corresponding to the
respective 9-, 55-, and 21-kDa proteins reported for Ad7
(Dijkema et al., 1982).
E2
The E2 transcriptional unit is also divided into two re-
gions called E2A and E2B. The E1 transcriptional transac-
tivators initiate transcription from the E2 promoters to pro-
duce transcripts that encode for three proteins required for
viral DNA replication (Shenk, 1996). The putative E2A
promoter has previously been characterized for group B Ad3
and compared to group C Ad2 (Heysen et al., 1991). Sequence
analysis of the Ad11 E2A promoter region revealed no TATA-
binding element, one TATA-like element (T1), and no E2F,
ATF, or SP-1 transcription factor-binding sites.
Table 1
Previously published nucleotide sequences for human adenovirus type 11 and sequences of Ad35, Ad34 and Ad7 used for primer design
Sequence origin Genbank
Accession No.
Reference % Homology vs this
sequence/differences
Sequenced
region
Ad11p complete AY163756 This report 100 1–34794
Ad11p E3 region M94458 Mei and Wadell, 1992 99.95 (1/2481) 27744–29723
Ad11a E3 region M94459 Mei and Wadell, 1992 96.7 FSU (1966 bp)
Ad11p fiber L08231 Mei and Wadell, 1993 99.95 (1/1980) 29718–32198
Ad11a fiber L08232 Mei and Wadell, 1993 96.3 FSU (2481 bp)
Ad11 Hexon AF161570 Allard et al, 2001 100 (0/253) 18299–18551
AJ272606 Unpublished 100 (0/571) 20214–21082
AJ250782 Unpublished 100 (0/301) 18274–18574
AB018424 Takeuchi et al, 1999 99.7 (4/1536) 18431–19966
Ad11 VA RNA U52569 Ma and Mathews, 1996 97.5 (9/354) 10315–10668
U10672 Kidd et al, 1996 100 (0/162) 10431–10592
Ad35 complete AX049983 Unpublished 98 1–34794
Ad35 L4, E3, L5 U32664 Flomenberg et al, 1988 94 26513–31813
Ad34 right ITR M62712 Chen and Horwitz, 1990 96 1–1038c
Ad7 left 31% X03000 Multiple references 84 FSU (10948 bp)
Ad7 penton AD001675 Unpublished 84 FSU (1641 bp)
Ad7 DBP K02530 Quinn and Kitchingman, 1984 81 FSU (1657 bp)
Note. FSU, full sequence undetermined. c, complementary strand.
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A predicted Ad11 DNA-binding protein of 57.5 kDa was
found within Ad11 E2A. Amino acid sequence alignment of
DBP from groups A–F suggested that Ad4 DBP was closest
to the group B DBPs (Fig. 2a, Table 3) and this was
confirmed by phylogenetic clustal analysis (Fig. 2b). Within
E2B two predicted proteins were identified corresponding to
a 70.9-kDa terminal protein precursor (pTP) and a 124.6-
kDa DNA polymerase.
E3
The adenovirus E3 region encodes for a series of proteins
that are not needed for efficient viral growth in vitro. These
proteins are known to counteract host antiviral responses
during disease pathogenesis and their roles include inhibi-
tion of CTL and TNF--mediated infected cell lysis (Wold
and Gooding, 1991; Wold et al., 1999). The predicted tran-
scription initiation start site for Ad11 E3 was identified as a
TATAAAA sequence. Eight E3 ORFs were identified en-
coding predicted proteins of 11.7, 14.6, 18.4, 20.1, 20.8,
10.1, 14.9, and 15 kDa. All of the proteins are homologues
of existing Ad E3 proteins, although the 20.1- and 20.8-kDa
protein ORFs cannot be found within E3 of group C viruses
such as Ad2 (Signas et al., 1986). Group B Ads are known
to encode up to nine E3 proteins depending on whether they
belong to subgroup B:1 or B:2. The group B:1 E3 prototype
is Ad3 which encodes for a protein of 9 kDa, present
between its 20.8- and 10.1-kDa homologue ORFs, in addi-
tion to homologues of all the identified Ad11 proteins
(Signas et al., 1986; Mei and Wadell, 1992). This 9-kDa
protein is also present in Ad7 and is not found in B:2 Ads
11 or 35 (Flomenberg et al., 1988; Mei and Wadell, 1992).
Eight predicted proteins have also been identified for the
B:2 Ad serotypes 14 and 35 (unpublished GenBank Acces-
sion Number AB070505, Basler et al., 1996). Putative
splice acceptor and donor sites (Table 2) were predicted
using the splice site finder program.
E4
Unlike the other early transcripts, the E4 region proteins
do not have similar roles (for review, see Leppard, 1997). In
the best-studied example of Ad5, E4 is known to produce
more than 18 viral mRNAs (Tigges and Raskas, 1984;
Virtanen et al., 1984) that are produced from a single tran-
scriptional start site and by differential splicing of at least
six ORFs. The putative transcriptional start site for Ad11 E4
was identified as a TATATATATA motif (34493c) along
with a predicted poly(A) signal at nucleotide 31812c.
Within Ad11 E4, five complete ORFs were identified cor-
responding to homologues of the previously named Ad5
ORFs 1, 2, 3, 4, and 6, and these ORFs encode for respec-
tive proteins of 13.9, 14.3, 13, 13.6, and 33.2 kDa. Splice
acceptor and donor sites (Table 2) were predicted for ORFs
1, 2, 3, 4, and 6 using the splice site finder program.
Although not determined in this study, it is likely that addi-
tional mRNA species exist for Ad11 E4. Sequence analysis
with the splice site finder program revealed 24 potential splice
donor and 36 potential splice acceptor sites within the Ad11 E4
region (data not shown); however, mRNA analysis is needed
to confirm the presence of further E4 mRNA species.
Intermediate region
The intermediate-region genes within human adenovi-
ruses produce two proteins termed pIX and pIVa2. The pIX
protein acts as both a structural component of the virus and
a transcriptional activator of the major late promoter (MLP)
(Lutz et al., 1997; van Ostrum and Burnett, 1985). An ORF
corresponding to Ad11 pIX was found that encodes a pro-
tein of 139 amino acids. In common with the group B Ads
3 and 7, no TATA box was found upstream for Ad11 pIX
(Dijkema et al., 1982; Engler, 1981). The IVa2 protein is
known to have roles in activation of the major late promoter
and genome packaging (Tribouley et al., 1994; Zhang et al.,
2001). An Ad11 IVa2 homologue of 449 amino acids in
length was found; however, no TATA box was found up-
stream for Ad11 pIVa2. It has previously been shown that
no Ad7 proteins are able to trans complement packaging of
genomes containing the Ad5 packaging signal into Ad7
capsids and that for this to occur expression of Ad5 IVa2 is
needed (Zhang et al., 2001). Amino acid sequence align-
ment reveals that the major region of variation among Ad5,
7 and 11 IVa2 is over the N-terminal 74 amino acids (data
not shown). Over this region the Ad11 sequence is closest to
Ad7, which in turn is closer to Ad5 than Ad11. This sug-
gests that similar to Ad7, the Ad11 IVa2 protein may not be
able to complement genomes containing the Ad5 packaging
signal. It is likely that subgroup-specific interactions occur
between the IVa2 protein and packaging signals in order to
facilitate genome encapsidation and that these interactions
require a domain found within the N-terminus of IVa2.
Late genes
The late coding regions of adenoviruses are organized
into one primary transcription unit that is processed, by
utilization of differential poly(A) sites, to produce multiple
distinct mRNAs. For human adenoviruses, depending on
which poly(A) signal is used, each mRNA is grouped into
one of five families called L1–L5 initiated from a common
major late promoter. All late RNA species from L1–5 con-
tain a 5 noncoding region called the tripartite leader se-
quence (TPL). Three regions, called the 1st, 2nd, and 3rd
leaders, make up the TPL and sometimes an additional i
leader sequence is also included in the mRNA.
Although different in sequence, the TPL organization of
group B Ads is similar to that of group C (Kidd et al., 1996).
The spacing between the TATA box, inverted CCAAT
motif, and 1st leader sequence is conserved among Ads 3, 5,
and 7 (Engler et al., 1981). This is also true for Ad11 with
the 1st leader sequence beginning 25 nucleotides down-
stream of the predicted TATAAAA box (nt 5888–5894)
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and an inverted CCAAT box 45 nucleotides upstream. Al-
though highly homologous to Ad5 and 7, the Ad11 TPL has
different nucleotides at some splice junctions. For the 2nd
and 3rd Ad11 leaders, the beginning of the predicted splice
acceptor contains TT and GG nucleotides, which is in contrast
to Ad5 and 7 that contain CT and GT. Unlike for the TPL, the
splice donor and acceptor sites for the Ad11 i leader were
completely conserved among the three serotypes.
L1
The RNA transcripts from the L1 RNA family of Ad11
share a predicted poly(A) signal that can be found at nucle-
otide 13608. Two L1 ORFs were found corresponding to
proteins of 43.1 and 61.1 kDa that are homologues of the Ad
proteins L1-52/55K and pIIIa. The L1-52/55K protein is a
scaffold protein thought to facilitate assembly of the capsid
Fig. 2. Analysis of adenovirus subgroups A–F DNA binding proteins. (a) Multiple amino acid sequence alignment of groups A–F DBP. Conserved regions
CR1–3 are indicated along with the zinc-binding domain. High consensus amino acids (90%) are shown in bold upper case and low consensus amino acids
(50%) are indicated in light upper case. Serotype and GenBank Accession Numbers are indicated for each adenovirus. (b) Phylogenetic tree generated using
cluster algorithm analysis of groups A–F DBP amino acid sequences. Adenovirus serotype and subgroup are shown to the right along with sequence GenBank
Accession Numbers. Amino acid distance diversity is shown below the tree.
Table 2
Genome organization of Ad11p
Region Gene
product
Transcription
start site
ATG Stop Splice
donor site
Splice
acceptor
Poly(A)
signal(s)
E1A 6.5 kDa 476 568 1336 639 1232 1499
25.7 kDa 476 568 1440 1054 1232 1499
29.1 kDa 476 568 1440 1147 1232 1499
E1B 20 kDa 1556 1610 2152 N N 3922
54.9 kDa 1556 1915 3399 N N 3922
10 kDa 1556 1915 3486 2178 3478 3922
pIX pIX ND 3483 3902 N N 3922, 3926
E2A DBP 26416c 23401c 21845c ND ND 21807c
E2B pTP 10354c 8438c ND ND 3968c
DNA Pol 8435c 5067c ND ND 3968c
IVa2 IVa2 ND 5588c 3964c 5576c 5297c 3968c
E3a 11.7 kDa 26866 27184 27501 26917 26999 30619
14.6 kDa 26866 27455 27850 26917 27341 30619
18.4 kDa 26866 27835 28335 26917 27708 30619
20.1 kDa 26866 28355 28900 26917 28353 30619
20.8 kDa 26866 28918 29481 26917 28916 30619
10.1 kDa 26866 29525 29800 26917 29508 30619
14.9 kDa 26866 29805 30209 26917 29715 30619
15 kDa 26866 30202 30609 26917 29887 30619
E4 ORF1 34493c 34413c 34036c N N 31812c
ORF2 34493c 33990c 33601c 34420c 34008c 31812c
ORF3 34493c 33604c 33251c 34420c 33633c 31812c
ORF4 34493c 33242c 32874c 34420c 33314c 31812c
ORF6 34493c 32971c 32072c 34420c 33078c 31812c
L1 43 kDa 5888 10647 11813 9579 10647 13608
pIIIa 5888 11839 13602 9579 11839 13608
L2 Penton 5888 13682 15367 9579 13326 17334
pVII 5888 15379 15957 9579 15225 17334
pV 5888 16000 17055 9579 15992 17334
pX 5888 17171 17314 9579 17082 17334
L3 pVI 5888 17398 18138 9579 17398 21790
Hexon 5888 18254 21100 9579 17777 21790
23K 5888 21137 21766 9579 20595 21790
L4 100K 5888 23432 25870 9579 22909 27490
22K 5888 25602 26177 9579 25568 27490
33K 5888 26059 26451 9579 25568 27490
pVIII 5888 26501 27184 9579 26352 27490
L5a Fiber 5888 30811 31788 9579 30811 31791
Note. N, no splicing predicted. ND, data not determined. c, complementary strand. a, sequence analysis of these areas have been described elsewhere. Splice sites
for E1 and IVa2 are based on homology with Ad7 homologues. Predicted splice sites for E3, E4, and L1–5 were predicted with the splice site finder program.
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during virus assembly (Hasson et al., 1989) and also facil-
itate genome encapsidation via interactions with IVa2 (Gus-
tin et al., 1996; Gustin and Imperiale, 1998). The Ad11
L1-52/55K protein of 388 amino acids in length is the first
predicted group B homologue. The pIIIa protein is a capsid
structural component that associates with hexon units that
surround the penton and bridge hexons with polypeptide VII
of the core (Everitt et al., 1973, 1975). The Ad11 pIIIa of
587 amino acids is the only identified group B homologue.
L2
L2 RNA transcripts of Ad11 share a putative poly(A)
signal at nucleotide 17334. Three ORFs are found within the
L2 family of RNAs comprising 62.3-, 21.3-, and 39-kDa
protein homologues of pIII (penton), pVII, and pV. The pIII
polypeptide associates as five copies to form the penton
base, found at each vertex of the icosahedral capsid (Shenk,
1996). The Ad11 pIII polypeptide is 561 amino acids in
length and contains the RGD motif that is conserved among
most human Ad serotypes and is involved in virus internal-
ization through interaction with different classes of integrins
(Wickham et al., 1993). The pVII and pV polypeptides are
constituents of the Ad core with pVII being the major core
protein and pV a bridge between the core and penton base
(Shenk, 1996). The putative Ad11 pVII and pV proteins are
192 and 351 amino acids in length. In addition to the pIII,
pVII, and pV polypeptides another ORF encoding a protein
of 47 amino acids was identified between pV and the L2
poly(A) signal. This protein is the Ad11 polypeptide pX
homologue, also known as mu, and has no known function.
L3
A predicted poly(A) signal at nucleotide 21790 indicates
the end of the Ad11 L3 RNA transcripts. Three ORFs were
identified within Ad11 L3 corresponding to pVI, pII
(hexon), and L3-23K protein homologues of 23.3, 105.3,
and 23.2 kDa. Polypeptide pVI is a capsid component that
associates with the Ad hexon and likely acts as a bridge
between the capsid and core components of the virion
(Shenk, 1996). The Ad11 pVI homologue is 246 amino
acids in length. The adenovirus pII protein trimerizes with
itself to form the major capsid structural component called
the hexon capsomere (Shenk, 1996). For Ad11 the pII
polypeptide is 948 amino acids long and shows high overall
homology with hexon sequences of other group B Ads. For
Ad11, variations in amino acid sequence are found within
seven hypervariable regions (Crawford-Miksza and
Schnurr, 1996) when compared to other group B hexons
(Fig. 3a), but outside of these regions few differences are
seen. Phylogenetic cluster analysis of complete group B
hexon sequences revealed three clusters of homology (Fig.
3b). Within the clusters, Ad11 was grouped with Ads 35,
21, and 34, Ad3 was grouped with Ad7, and Ad16 was
unique. The Ad L3-23K protein is otherwise known as the
adenovirus protease and is an essential protein for Ad prop-
agation. The Ad11 L3-23K is 209 amino acids in length and
shows homologies of 78.2 and 89.5% with Ads 2 and 3.
L4
L4 RNA transcripts of Ad11 share a putative poly(A)
signal at nucleotide 27490. Four ORFs are present corre-
sponding to a 90.2-kDa L4-100K homologue, a 21.2-kDa
protein, a 14.4-kDa protein, and 25.2-kDa pVIII homo-
logue. L4-100K is a nonstructural protein involved in hexon
assembly (Oosterom-Dragon and Ginsberg, 1981), selective
activation of late viral protein synthesis (Hayes et al., 1990),
and inhibition of Granzyme B-mediated lysis (Andrade et
al., 2001). Ad11 L4-100K is 812 amino acids in length. The
L4-33K protein is conserved throughout the Mastadenoviri-
dae, is not essential for virus propagation, and has no known
function (Fessler and Young, 1999). For Ad11 two overlap-
ping ORFs are present in the location of L4-33K and they
encode proteins of 191 and 130 amino acids. These proteins
are termed L4-22K and L4-33K according to the nomen-
clature of the two ORFs present in Ad40. Like pVI,
polypeptide pVIII is able to associate with the Ad hexon
forming a possible link between the hexon capsomere and
core capsid components (Shenk, 1996). The Ad11 pVIII
protein is 227 amino acids in length.
L5
The predicted poly(A) signal for the Ad11 L5 transcript
is found at nucleotide 31791 and within L5 one single ORF
is found corresponding to the Ad11 adenovirus fiber. The
Table 3
Protein sequence identities between Ad11 and other subgroup human
adenoviruses
Identity (%)
Subgroup: A C D E F
Ad11 protein: Ad12 Ad5 Ad17 Ad4 Ad40
DBP 52.2 55.1 60.1 71.9 48
pTP 76.6 80.2 79.6 88.8 72.7
Pol 74.9 77.9 80.4 86.5 72
pIVa2 77.3 78.5 83.1 ND 78.5
pIX 57.9 45 ND ND 55.8
52K 73.1 74.4 81.2 ND 79.2
pIIIa 73.2 74.7 79.3 ND 72.2
Penton 71.3 69.5 75.5 ND 71.7
pVII NH 70.6 NH 86.5 69.9
pV 57.7 58.7 61.9 ND 55
pVI 63.9 64.6 71.5 ND 59.6
Hexon 77.14 76.6 81.3 82.4 78.4
23K 80 78.2 77.6 75.5 78
100K 64 61 59 ND 62
pVIII 77.4 79.7 79.7 ND 79
Note. Percentage identities were determined using the SIM program with
default parameters (gap open penalty of 12, gap extension penalty of 4).
NH, no homolog identified. ND, not determined.
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Ad fiber is produced as a single polypeptide, which trimer-
izes to produce a structure containing tail, shaft, and knob
domains. For all Ads the knob domain is the primary de-
terminant of tissue tropism through its interaction with cell
surface receptors. For Ad11p the fiber sequence has previ-
ously been reported and is 100% identical to the sequence
Fig. 3. Analysis of subgroup B adenovirus hexons. (a) Multiple amino acid sequence alignment of hypervariable regions (HVR) 1–7 from group B adenovirus
hexons. For each serotype the sequence begins 30 amino acids N-terminal to HVR1 and ends 26 amino acids C-terminal to HVR7. High consensus amino
acids (90%) are shown in bold upper case and low consensus amino acids (50%) are indicated in light upper case. Hypervariable regions 1–7 are indicated
along with the serotype, strain and GenBank Accession Numbers for each adenovirus. (b) Phylogenetic tree generated using cluster algorithm analysis of
group B hexon amino acid sequences. Adenovirus serotype and subgroup are shown to the right along with sequence GenBank Accession Numbers. Amino
acid distance diversity is shown below the tree. Note: No complete sequence for Ad14 hexon is available.
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reported here (Table 1). The Ad11p fiber polypeptide is 325
amino acids in length corresponding to a protein of 36.2
kDa. Amino acid sequence alignment of the Ad11p fiber
with existing group B fiber sequences found in GenBank
suggested that four groups of fiber may be present among
the group B Ads with great variation in amino acid se-
quences seen between each group (Fig. 4a). Subsequent
phylogenetic analysis showed that four predominant clus-
ters of homology are found and that the clustal grouping of
group B fibers is not restrictive of B:1 or B:2 status (Fig.
4b). The Ad11p fiber shows overall amino acid homologies
of 60.4, 62, and 62% with cluster 1 serotypes 21, 34p, and
35. Ad11p is a member of cluster 2 along with serotypes
34a, 7a, 7d, 11a, and 14 which show homologies of 98.8,
93.5, 93.2, 92.3, and 92.9. Cluster 3 contains Ad3 and an
unidentified strain of Ad7 that show homologies of 58.4 and
57.8%, respectively. Ad16, which shows the lowest homol-
ogy at 52%, is the only member of cluster 4 and is the sole
group B fiber to show a variation in size among putative
structural elements as it contains 8 shaft repeats instead of
six. In contrast to a previous report (Havenga et al., 2002),
the phylogenetic analysis shown here suggests that the
Ad11p fiber is in a cluster containing B:1 Ad7a and Ad7d.
This is interesting since it demonstrates that a more distant
relative of Ad11 shows greater homology in the fiber region
than the closely related serotypes 34p and 35.
Phylogeny and origin
It is commonly accepted that Ad11 is very closely related
to serotypes 34 and 35 and this is based on similar fragment
comigration patterns during restriction genome typing (Li et
al., 1991). During this study the similarity between Ad11
and Ad35 was reaffirmed when we aligned the genome of
Ad11 with an unpublished sequence for Ad35 (GenBank
Accession Number AX049983). An overall DNA homology
of greater than 98% was found, with the majority of base
pair mismatches seen within the hexon and fiber region
genes (data not shown). Amino acid sequence alignment
and phylogenetic analysis reveal that despite the variations
seen within hexon at the nucleotide level, the hexon of Ad11
is most closely related to the Ad35 hexon (Fig. 3). Since the
hexon is a determinant of neutralization and the hypervari-
able regions do not encompass domains required for structural
integrity, adenoviruses are able to evolve within this region in
order to avoid neutralizing antibodies in vivo. This likely
explains the variations seen between Ad11 and 35 in hexon.
Within fiber the DNA sequence diversity seen between
Ad11 and 35 is not so easily explained. At the protein level
the fibers show 98.7% identity over the first 76 amino acids,
encompassing the tail domain and first two repeats of the
shaft, after which the sequences become very diverse (Fig.
4a). Over this diverse region the Ad11p fiber is highly
homologous (90%) to the B:2 Ads 11a, 14, and 34a, and
the phylogenetically more distantly related B:1 Ads 7a and
7d (Fig. 4b). This similarity in fiber amino acid sequence
between Ad11 and Ad7 may be explained by an evolution-
ary recombination event in which a direct fiber substitution
occurred between prototype genomes of B:1 (Ad7) and B:2
(Ad35) (Fig. 5a). Ad35 is commonly associated with im-
munocompromised hosts, and substitution with the fiber
from Ad7, which is predominantly found in respiratory
tissue, may explain the tropism for respiratory tissue shown
by some strains of Ad11. It is also feasible that the genomes
of Ad35 and/or Ad34p resulted from a direct fiber substi-
tution from B:1 (Ad21) to B:2 (Ad11) genomes (Fig. 5a)
since the Ad21 fiber shows90% homology with serotypes
34p and 35 (Fig. 4b). Unlike Ad11, Ad21 has been isolated
from patients with keratoconjunctivitis (Darougar et al.,
1978) and this is also true of Ad34 (Saitoh-Inagawa et al.,
2001). Alignment of available genomic sequences immedi-
ately surrounding group B fiber genes revealed regions of
high homology between serotypes (Fig. 5b). In the 184 bp
immediately preceding the fiber start codon all serotypes
showed homologies of greater than 95% with the exception
of Ad3. Over the first 42–50 bp after the fiber stop codons
some diversity was seen between serotypes; however, a
highly conserved region of 32 bp was found immediately
after. It is possible that regions of homology surrounding the
fiber could have mediated homologous recombination be-
tween genomes from different serotypes to produce Ad11.
Alternatively genomic sequences encoding the 5 fiber tail
and first two repeats of the shaft could have mediated an
in-frame partial fiber substitution with sequences 3 to fiber.
It has previously been suggested that Ad4 (the prototype
subgroup E Ad) was derived from a recombination event
between group B and group C Ads resulting in a virus that
contains left-end genomic sequences from group B and
right-end sequences from group C (Gruber et al., 1993).
This was based on the observation that Ad4 proteins from
the left end show high homology with group B proteins and
the fiber, found within the right end of the genome, shows
high homology with those of group C. This theory supports
the idea that rescue of functional virus following recombi-
nation between genomes of alternate serotypes can occur,
although the proposed recombination does not involve sub-
stitution of a single gene as we propose here for Ad11.
When the group E (chimpanzee derived) SAV25 genome
was aligned with Ad11 a homology of 75% was seen which
is greater than the values of 64, 54, 68, and 52% when
compared to group A (Ad12), C (Ad5), D (Ad17), and F
(Ad40). In fact, the homology between Ad11 and SAV25
was the highest seen between any two subgroups and this
led us to investigate further the similarities between group B
and E Ads. For the recombination theory of Gruber et al. to
hold true, sequences proximal to the fiber within group E
Ads, such as E3 and E4, should be closer to group C Ads
than B. When the amino acid sequences of E4 ORFs 3 and
6 from groups A–F were aligned, SAV25 and Ad11 were
found to be very similar while Ad5 ORFs 3 and 6 were the
most distinct of all subgroups (data not shown). Further-
more, analysis of the sequence for SAV25 (GenBank Ac-
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Fig. 4. Analysis of subgroup B adenovirus fibers. (a) Multiple amino acid sequence alignment of group B adenovirus fibers. High consensus amino acids
(90%) are shown in bold upper case and low consensus amino acids (50%) are indicated in light upper case. Putative tail, shaft, and knob domains are
indicated along with the serotype, strain and GenBank Accession Number for each adenovirus. (b) Phylogenetic tree generated using cluster algorithm
analysis of group B adenovirus fiber amino acid sequences. Adenovirus serotype and subgroup are shown to the right along with sequence GenBank
Accession Numbers. Amino acid distance diversity is shown below the tree.
Fig. 5. (a) Schematic representation of proposed genome origins. Genomes for Ad11, Ad35, and group E Ads are shown as bold lines and substituted fibers
as bold arrows. Map units for each genome are shown along with the proposed origins of genome sequences. Values for homology between parental and
progeny genome sequences are indicated in parentheses. (b) Alignment of genomic sequences immediately 5 and 3 to group B fiber genes. High consensus
nucleotides (90%) are shown in bold case and low consensus nucleotides (50%) are indicated in light upper case. Serotype, strain, and GenBank
Accession Number for each Ad are shown. Conserved region (CR) is indicated. Note: No sequence is available for the Ad21 3 region.
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cession Number NC_003266) revealed eight putative E3
ORFs corresponding to direct homologues of the E3 pro-
teins found in Ad11 and including the 20.1- and 20.8-kDa
proteins not found in group C Ads (Signas et al., 1986). These
observations suggest that the right end of group E Ad genomes
is derived from a group B Ad and that the fiber sequence is the
only element derived from group C. This would mean that
group E Ads are the product of a recombination that resulted in
a group C fiber substitution into a group B genome in a manner
similar to what we have proposed for the Ad11 genome.
Overall summary
In this report we present the genome sequence of sub-
group B:2 human adenovirus type 11. Sequence analysis
demonstrated a highly conserved organization for a human
adenovirus and revealed ORFs for all predicted proteins of
a subgroup B human adenovirus. Comparison with existing
sequences for other human adenovirus serotypes showed
that the highest genome homology (98%) was with sub-
group B:2 Ad35 that only differed significantly in hexon
and fiber. Analysis of fiber amino acid sequences revealed
that the Ad11p fiber is closest to subgroups B:2 Ads 11a, 14,
and 34a, and subgroups B:1 Ads 7a and 7d. Based upon
these observations and analysis of genomic sequences sur-
rounding fiber we propose that Ad11 was evolutionarily
derived from a cross-serotype fiber substitution into the
Ad35 genome, or that Ad35 was derived in the same manner
from an Ad11 genome. Furthermore we propose that group
E Ads may also have originated from a group B Ad that had
its fiber substituted with a group C Ad fiber. Taken together
these data not only give us insight into the possible mech-
anisms of human Ad evolution but also provide important
information necessary for the construction of Ad vector
systems that utilize Ad11 as an alternative to Ad5.
Materials and methods
Virus strain and preparation of viral DNA
The virus used was of genome type Ad11p (Slobitski
strain) and was obtained from the American Type Culture
Collection (ATCC, VR-12). The Slobitski strain was orig-
inally derived from the stool of a patient with paralytic
poliomyelitis (Pereira et al., 1963). Virus was propagated in
HEp-2 cells (ATCC, CCL-23) and purified in CsCl gradi-
ents, and viral DNA was extracted using a previously de-
scribed method (Lieber et al., 1996).
Construction of plasmids
Viral DNA was deproteinized by treating with pronase
and then phenol/chloroform-extracted. In order to com-
pletely remove fragments of TP covalently linked to the
virus genome, DNA was incubated in 0.4 M NaOH for 1 h,
reannealed at 65°C, ethanol-precipitated, and blunted with
Klenow fragment (Hay et al., 1984). Blunted viral DNA was
digested with HindIII and then ligated with the plasmid
pPBGs3 digested with HindIII/HindII. A 1.3-kb left-end
fragment was rescued that contained a complete ITR se-
quence and sequences homologous to E1. Since no frag-
ment corresponding to the right end was rescued, a PCR
fragment corresponding to the right 2.8 kb was generated by
PCR utilizing known sequences for fiber and ITR. Follow-
ing amplification with specific primers for ITR-CTCTG-
CAGTTAATTAACATCATCAATAATATACCTTATGG
and Fiber-GCTCCGTGCGACTGCTGTTT, the right-end
fragment was cloned into the PstI and SnaBI sites of pP-
BGs3 containing the left-end fragment to generate pPBG-
shAd11-2. Plasmid pPBGshAd11-2 was linearized and used
to rescue a full-length Ad11 genome by homologous recom-
bination with Ad11 viral DNA in Escherichia coli BJ5183
cells (Chartier et al., 1996). The resulting plasmid was
labeled pBGAd11wt.
Sequencing
All sequencing was done using the plasmid pBGAd11wt
as a template. Reactions were run using Big Dye ready
reaction mix (Applied Biosystems) and samples were puri-
fied on G-50 columns (Pharmacia) before analyzing with an
ABI prism 377 sequencer (Applied Biosystems). Sequenc-
ing primers were designed based on existing sequences
available for the group B adenoviruses Ad11, Ad34, Ad35,
and Ad7 (Table 1). Of the group B adenoviruses Ad35 and
34 are the most closely related to Ad11, while Ad7 has the
most available sequences in the GenBank database. The
Hexon, E3, and fiber regions were sequenced based on the
available Ad11p sequences. Parts of E3 and L4 were se-
quenced using primers based on existing Ad35 sequences.
Ad34 sequences were used to sequence the right ITR and
part of E4. Ad7 sequences were used to design primers for
the left 13000-bp, penton base, and DNA-binding protein.
Chromosome walking was used to fill the remaining gaps.
DNA and protein analysis
Sequence assembly was carried out with the program
Clone Manager 5.03. Protein and nucleotide homology
searches were carried out using the NCBI BLAST program.
DNA and protein sequence alignments were carried out
using the Multalign program from the University of Tou-
louse (Corpet, 1988) or the online SIM alignment tool
(http://www.expasy.ch/tools/sim-prot.html). For phyloge-
netic tree analysis protein sequences were first aligned using
the ClustalW program on the EMBL-EBI website (http://
www.ebi.ac.uk/clustalw/). ClustalW alignments were then
fed into the TreeTop phylogenetic tree prediction program
at Moscow State University using the cluster algorithm
(http://www.genebee.msu.su/services/phtree_reduced.html).
Splice donor and acceptors sites with the highest score were
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predicted using the splice site finder program (http://www.
genet.sickkids.on.ca/ali/splicesitefinder.html) that uses
the algorithm of Shapiro and Senapathy (1987).
Ad11 sequence
The sequence reported here has been submitted to Gen-
Bank and assigned Accession Number AY163756.
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